What does it really take for your medical technology to be procured, evaluated, and adopted within South Africa’s healthcare system?

Understanding how healthcare purchasers and funders evaluate medical technologies is no longer optional; it’s a strategic advantage. Join industry leaders as they unpack procurement, Health Technology Assessment (HTA), and clinical protocol development, providing practical insights to help MedTech companies strengthen market access, engage more effectively with key decision-makers, and navigate evolving healthcare requirements.

Why You Should Attend

By attending this forum, you will:

• Gain first-hand insight into Netcare’s procurement strategy, supplier expectations, and future priorities.
• Understand how clinical evidence, HTA and protocol development influence the adoption of new medical technologies.
• Learn about the latest ISPOR and 1HTA developments, strategic priorities, and opportunities to build HTA capability.
• Discover practical ways to position your products for stronger engagement with hospitals, funders and procurement teams.
• Connect the dots between procurement, reimbursement, clinical evidence and market access to strengthen your commercial strategy.

Programme

10:00

Demystifying Private Hospital Procurement: Netcare
Presenter: Vash Raghununan, General Manager: Procurement Services, Netcare Hospital Group

Discover how procurement decisions are made within one of South Africa’s largest private hospital groups, including supplier expectations, current procurement developments, and the role of HTA, local manufacturing and SMMEs in procurement decision-making.

11:00

ISPOR & 1HTA Update
Presenter: Mark Brand, Founder, BrandTech & President, ISPOR South Africa Chapter

An update on ISPOR and 1HTA strategic priorities, emerging developments in HTA, opportunities for SAMED member engagement, upcoming initiatives, and capacity-building opportunities.

11:30

Discovery’s Surgical Risk Unit Methodology and Processes: Protocol Design Update
Presenter: Kershnee Chetty, Head of the Medical and Surgical Device Unit, Discovery

Gain insight into how clinical protocols are developed and updated, how evidence informs decision-making, the assessment of emerging technologies, and what MedTech companies need to know to successfully engage with protocol development processes.

Who Should Attend

• CEOs and Executive Managers
• Market Access Specialists
• Procurement Managers
• Supply Chain Leaders
• Regulatory and Medical Affairs Professionals
• Commercial and Business Development Managers

Note: This is a SAMED member only Forum.

Register: Click Here